Showing 35,231 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Harm reduction

New HRI report warns of HIV and Hepatitis C 'powder keg' in the European Union ahead of the 25th Harm Reduction International Conference (HR17)

Editor's pick
HIV / AIDS News From Medical News Today
10 May 2017
Hepatitis C treatment

BC-developed hepatitis C screening test personalizes treatment for patients

Editor's pick
The Globe and Mail
10 May 2017
Neurological & cognitive problems

Switching from efavirenz to lopinavir/ritonavir has no meaningful impact on neurological function, says UK study

News
10 May 2017

HIV update - 10th May 2017

May 2017
HIV prevention policy

Aiding and Abetting: Why Western Fundraising Fails to Stop AIDS Epidemics

Editor's pick
World Policy
9 May 2017
Harm reduction

From pill to needle: Prescription opioid epidemic may be increasing drug injection

Editor's pick
Manual Items
9 May 2017
Migrants, refugees & displaced people

Undocumented migrants more likely to be lost to follow-up and have poor virological outcomes after starting ART, Milan study confirms

News
9 May 2017
Harm reduction

Where harm reduction policies went up, hepatitis C incidence went down, study finds

Editor's pick
Science Speaks
9 May 2017
Government, leadership & policy

To End AIDS in the United States, Stay True to the National HIV/AIDS Strategy

Editor's pick
Project Inform
9 May 2017
UK health services

On borrowed time

Editor's pick
Drink & Drug News
8 May 2017
Undetectable viral load & treatment as prevention

Gay New Zealand welcomes removal of HIV meds restriction

Editor's pick
Gay New Zealand
8 May 2017
New & experimental hepatitis C treatment

Study points to new approach to battling hepatitis C infections

Editor's pick
Eurekalert
8 May 2017
PrEP

Gilead slowly rolls out ads for Truvada for PrEP — 4 years after approval

Editor's pick
Medical Marketing & Media
8 May 2017
Health services & systems

What is at Stake in ACA Repeal and Replace for People with HIV?

Editor's pick
Kaiser Family Foundation
8 May 2017
Pharmaceutical industry

The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 63 HIV/AIDS Patient Groups

Editor's pick
PatientView
8 May 2017
Hepatitis B

Besifovir and tenofovir exalidex look promising as new hepatitis B drugs

News
8 May 2017
HIV prevention policy

Kenya launches self-test kits and PrEP

Editor's pick
UNAIDS
5 May 2017
Travel

Korea Should Get Real on HIV

Editor's pick
Human Rights Watch Health
5 May 2017
Health services & systems

How pre-existing conditions became front and center in health care vote

Editor's pick
The Conversation
5 May 2017
Access to healthcare

HIV Community Leaders Denounce Passage of American Health Care Act By U.S. House of Representatives

Editor's pick
The Body
5 May 2017
Harm reduction

Naloxone is a heath intervention that can’t be effectively provided without the knowledge and social connections of people who inject drugs

News
5 May 2017
Global health targets

The Rural Challenge of HIV

Editor's pick
Inside Science
4 May 2017
Experiences of stigma

Fear of stigma is prompting young South Africans to seek early HIV treatment

News
4 May 2017
Access to healthcare

India betrays people living with HIV by approving law that undermines right to life

Editor's pick
International Treatment Preparedness Coalition (ITPC)
3 May 2017